[Three keys to the appropriate choice of oral antibiotic treatment in the respiratory tract infections].

R Menéndez, R Cantón, A García-Caballero, J Barberán
Author Information
  1. J Barberán: José Barberán, Servicio de Medicina Interna y Enfermedades infecciosas, Hospital Universitario HM Montepríncipe, Universidad San Pablo CEU. Madrid, Spain. jbarberan@ceu.es.

Abstract

Exacerbation of chronic obstructive pulmonary disease and community-acquired pneumonia are the most frequent infections of the lower respiratory tract in daily clinical practice. Antibiotic selection is a crucial component in its treatment and, in most cases, it is performed empirically. Scientific societies make therapeutic recommendations based on scientific evidence and / or expert recommendations that are of great help to clinicians. Beta-lactams, fluoroquinolones and macrolides are the most commonly used drugs for oral administration. From a practical point of view, there are three keys to the appropriate choice of oral antibiotic treatment, which are the effectiveness, safety and the ecological impact on the patient's microbiota, including the development of resistance, which will be assessed in depth in this review.

References

  1. Allergy. 2017 Sep;72(9):1288-1296 [PMID: 28370003]
  2. Rev Esp Quimioter. 2018 Oct;31(5):461-484 [PMID: 30284414]
  3. Eur J Clin Pharmacol. 2011 May;67(5):521-6 [PMID: 21234553]
  4. F1000Res. 2018 Jul 23;7: [PMID: 30079235]
  5. CNS Drugs. 2013 Dec;27(12):1021-48 [PMID: 24170642]
  6. Expert Opin Drug Saf. 2019 Nov;18(11):1055-1063 [PMID: 31500468]
  7. Nat Microbiol. 2018 Nov;3(11):1255-1265 [PMID: 30349083]
  8. Can J Infect Dis. 2002 Jan;13(1):54-61 [PMID: 18159374]
  9. J Thorac Cardiovasc Surg. 2019 Jan;157(1):109-119.e2 [PMID: 30528439]
  10. FEMS Microbiol Rev. 2011 Sep;35(5):977-91 [PMID: 21722146]
  11. Eur J Clin Microbiol. 1985 Jun;4(3):345 [PMID: 3160584]
  12. Arch Bronconeumol. 2010 Oct;46(10):543-58 [PMID: 20832928]
  13. Eur J Clin Microbiol Infect Dis. 2014 Jul;33(7):1065-79 [PMID: 24532008]
  14. J Antimicrob Chemother. 2017 Oct 1;72(10):2891-2897 [PMID: 29091190]
  15. Eur J Pharmacol. 2012 Jun 15;685(1-3):30-7 [PMID: 22542655]
  16. Expert Opin Drug Saf. 2008 May;7(3):295-304 [PMID: 18462187]
  17. Mol Pharmacol. 2001 Jan;59(1):122-6 [PMID: 11125032]
  18. Lancet Infect Dis. 2001 Sep;1(2):101-14 [PMID: 11871461]
  19. Eur J Clin Microbiol Infect Dis. 2005 Oct;24(10):649-53 [PMID: 16261307]
  20. Dig Dis. 2016;34(3):260-8 [PMID: 27028893]
  21. Expert Opin Drug Metab Toxicol. 2015 Jan;11(1):25-39 [PMID: 25423877]
  22. J Allergy Clin Immunol. 2015 Mar;135(3):745-52.e5 [PMID: 25262461]
  23. Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1):121-6 [PMID: 24674687]
  24. Drug Saf. 2012 Jul 1;35(7):589-98 [PMID: 22702640]
  25. Pharmacotherapy. 2007 Apr;27(4):542-5 [PMID: 17381381]
  26. Int J Antimicrob Agents. 2016 Jul;48(1):1-10 [PMID: 27216385]
  27. Toxicology. 2005 Aug 15;212(1):24-36 [PMID: 15890441]
  28. Expert Opin Drug Saf. 2018 May;17(5):499-508 [PMID: 29633867]
  29. Int J Antimicrob Agents. 2012 Jul;40(1):18-23 [PMID: 22578763]
  30. Int J Clin Pract. 2019 May;73(5):e13331 [PMID: 30809871]
  31. Chang Gung Med J. 2011 Sep-Oct;34(5):461-7 [PMID: 22035890]
  32. Dig Dis Sci. 2016 Aug;61(8):2406-2416 [PMID: 27003146]
  33. Drug Saf. 2010 May 1;33(5):353-69 [PMID: 20397737]
  34. Clin Pharmacokinet. 1992 Aug;23(2):106-31 [PMID: 1511528]
  35. Eur J Clin Microbiol Infect Dis. 2008 Aug;27(8):679-83 [PMID: 18299905]
  36. J Antimicrob Chemother. 2018 Mar 1;73(3):772-778 [PMID: 29237024]
  37. Eur Respir J Suppl. 2002 Jul;36:9s-19s [PMID: 12168752]
  38. Blood Rev. 2010 Jul-Sep;24(4-5):143-50 [PMID: 20650555]
  39. Clin Infect Dis. 2015 Jan 15;60(2):203-7 [PMID: 25301207]
  40. Expert Opin Drug Saf. 2012 May;11(3):381-99 [PMID: 22220627]
  41. Ann Pharmacother. 2009 Feb;43(2):304-15 [PMID: 19193579]
  42. Infect Dis Clin North Am. 2000 Jun;14(2):409-33, ix [PMID: 10829263]
  43. Chest. 2013 Sep;144(3):999-1007 [PMID: 23670047]
  44. Perm J. 2009 Spring;13(2):12-8 [PMID: 21373225]
  45. Respir Med. 2018 Jul;140:115-121 [PMID: 29957272]
  46. Gastroenterology. 2015 Jun;148(7):1340-52.e7 [PMID: 25754159]
  47. Pharmacotherapy. 2016 Jun;36(6):679-93 [PMID: 27138564]
  48. Nat Rev Microbiol. 2017 Oct;15(10):630-638 [PMID: 28626231]
  49. BMC Pulm Med. 2019 Jul 1;19(1):118 [PMID: 31262278]
  50. Gut. 1992 Mar;33(3):397-401 [PMID: 1568663]
  51. Microb Drug Resist. 2008 Mar;14(1):13-21 [PMID: 18346008]
  52. J Chemother. 2014 Jun;26(3):150-3 [PMID: 24090971]
  53. J Antimicrob Chemother. 2015 Jan;70(1):41-7 [PMID: 25261419]
  54. Br J Haematol. 2011 Sep;154(5):644-53 [PMID: 21749359]
  55. Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2439-44 [PMID: 22450740]
  56. Drug Saf. 1993 Nov;9(5):346-64 [PMID: 8280403]
  57. Clin Exp Allergy. 2005 Sep;35(9):1234-42 [PMID: 16164453]
  58. BMJ. 2018 Mar 8;360:k678 [PMID: 29519881]
  59. Clin Ther. 2006 Nov;28(11):1857-66 [PMID: 17213006]
  60. Microbiology (Reading). 2010 Nov;156(Pt 11):3216-3223 [PMID: 20705661]
  61. J Allergy Clin Immunol. 2015 Apr;135(4):972-976 [PMID: 25457154]
  62. BMC Ophthalmol. 2003 Oct 06;3:10 [PMID: 14529574]
  63. Antimicrob Agents Chemother. 2011 Jun;55(6):2788-94 [PMID: 21464255]
  64. Clin Infect Dis. 1992 Sep;15(3):563-4 [PMID: 1387810]
  65. Respirology. 2016 Nov;21(8):1472-1479 [PMID: 27417291]
  66. Toxicology. 2006 Dec 7;228(2-3):239-48 [PMID: 17027138]
  67. J Antimicrob Chemother. 2015 Apr;70(4):971-8 [PMID: 25525200]
  68. JAMA. 2017 Jul 4;318(1):82-83 [PMID: 28672303]
  69. Vaccine. 2015 Oct 13;33(42):5691-5699 [PMID: 26341563]
  70. Immunol Allergy Clin North Am. 2017 Nov;37(4):785-815 [PMID: 28965641]
  71. Aorta (Stamford). 2019 Apr;7(2):35-41 [PMID: 31529426]
  72. Rev Esp Geriatr Gerontol. 2014 Nov-Dec;49(6):279-91 [PMID: 24873864]
  73. J Pediatr. 2016 Nov;178:125-129.e1 [PMID: 27522443]
  74. Int J Antimicrob Agents. 2006 Sep;28 Suppl 2:S115-27 [PMID: 16904873]
  75. N Engl J Med. 2013 May 2;368(18):1704-12 [PMID: 23635050]
  76. Antimicrob Agents Chemother. 1994 Mar;38(3):409-14 [PMID: 8203832]
  77. Clin Infect Dis. 2015 Feb 15;60(4):566-77 [PMID: 25409476]
  78. BMJ Open. 2015 Nov 18;5(11):e010077 [PMID: 26582407]
  79. Drug Saf. 2019 Sep;42(9):1025-1033 [PMID: 31077091]
  80. J Clin Neurosci. 2011 Mar;18(3):313-8 [PMID: 21269833]
  81. J Chemother. 2009 Aug;21(4):378-82 [PMID: 19622454]
  82. Drug Saf. 2017 Aug;40(8):663-677 [PMID: 28397186]
  83. Multidiscip Respir Med. 2018 Nov 2;13:40 [PMID: 30410757]
  84. JAMA Intern Med. 2015 Nov;175(11):1839-47 [PMID: 26436523]
  85. J Allergy Clin Immunol. 2015 Sep;136(3):685-691.e3 [PMID: 25930196]
  86. Expert Opin Drug Saf. 2013 Jul;12(4):497-505 [PMID: 23651367]
  87. Enferm Infecc Microbiol Clin (Engl Ed). 2020 Feb;38(2):79-83 [PMID: 30409509]
  88. Postgrad Med. 2017 Sep;129(7):715-724 [PMID: 28770640]
  89. J Allergy Clin Immunol Pract. 2015 Nov-Dec;3(6):1006-7 [PMID: 26553624]
  90. Drug Saf. 2006;29(10):889-96 [PMID: 16970512]
  91. Eur Respir J. 2005 Dec;26(6):1138-80 [PMID: 16319346]
  92. Clin Infect Dis. 2014 Oct 15;59(8):1113-22 [PMID: 25048853]
  93. J Infect. 2019 Jul;79(1):7-14 [PMID: 31100360]
  94. Int J Cardiol. 2019 Jan 1;274:299-302 [PMID: 30309682]
  95. Drugs. 2008;68(17):2469-81 [PMID: 19016574]
  96. Am J Med. 2008 Jul;121(7):572-6 [PMID: 18589051]
  97. J Am Coll Cardiol. 2018 Sep 18;72(12):1369-1378 [PMID: 30213330]
  98. Infection. 2016 Feb;44(1):65-76 [PMID: 26370552]
  99. Exp Eye Res. 2005 May;80(5):643-50 [PMID: 15862171]
  100. Mayo Clin Proc. 2005 Mar;80(3):405-10 [PMID: 15757022]
  101. N Engl J Med. 2014 Oct 23;371(17):1619-28 [PMID: 25337751]
  102. J Pharmacol Pharmacother. 2014 Apr;5(2):83-7 [PMID: 24799810]
  103. Clin Infect Dis. 2004 May 15;38 Suppl 4:S341-5 [PMID: 15127367]
  104. J Antimicrob Chemother. 2018 Dec 1;73(12):3442-3453 [PMID: 30165476]
  105. J Allergy Clin Immunol. 2014 Mar;133(3):790-6 [PMID: 24188976]
  106. Clin Infect Dis. 2008 Sep 15;47(6):735-43 [PMID: 18694344]
  107. BMC Pulm Med. 2014 Jun 26;14:103 [PMID: 24964956]
  108. JAMA. 2013 Dec 18;310(23):2544-53 [PMID: 24346990]
  109. PLoS One. 2013 Aug 12;8(8):e71001 [PMID: 23951065]
  110. J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):816-7 [PMID: 25439383]
  111. Ann Otol Rhinol Laryngol. 2000 Apr;109(4):435-7 [PMID: 10778901]
  112. Int J Antimicrob Agents. 2009 Mar;33(3):194-200 [PMID: 18835137]
  113. Lancet Respir Med. 2019 Jan;7(1):69-89 [PMID: 30553848]
  114. Acta Ophthalmol. 2016 Aug;94(5):e251-9 [PMID: 26846201]
  115. Curr Allergy Asthma Rep. 2014 Nov;14(11):476 [PMID: 25216741]
  116. Respir Med. 2012 Mar;106(3):451-8 [PMID: 22182341]
  117. Genome Med. 2016 Apr 13;8(1):39 [PMID: 27074706]
  118. Ann Transl Med. 2017 Jun;5(12):251 [PMID: 28706919]
  119. J Orthop Res. 2011 Jan;29(1):67-73 [PMID: 20602464]
  120. J Infect. 2013 Dec;67(6):497-515 [PMID: 23973659]
  121. J Antimicrob Chemother. 2014 Apr;69(4):881-91 [PMID: 24324224]
  122. Antimicrob Agents Chemother. 2008 May;52(5):1880-3 [PMID: 18347113]
  123. J Antimicrob Chemother. 2009 Jun;63(6):1215-22 [PMID: 19307171]
  124. Med Clin (Barc). 2013 Mar 2;140(5):223.e1-223.e19 [PMID: 23276610]
  125. Ther Clin Risk Manag. 2013;9:55-64 [PMID: 23430960]
  126. Immunohematology. 2014;30(2):66-79 [PMID: 25247621]
  127. Clin Infect Dis. 2004 Mar 1;38(5):640-5 [PMID: 14986246]
  128. J Antimicrob Chemother. 2013 Sep;68(9):1951-61 [PMID: 23620467]
  129. Clin Infect Dis. 2016 Dec 10;64(5):666-674 [PMID: 27940946]
  130. Rev Rhum Engl Ed. 1999 Jul-Sep;66(7-9):419-21 [PMID: 10526383]
  131. PLoS One. 2016 Jul 20;11(7):e0159406 [PMID: 27438379]
  132. Drug Saf. 2011 Jun 1;34(6):465-88 [PMID: 21585220]
  133. Nat Rev Immunol. 2013 Nov;13(11):790-801 [PMID: 24096337]
  134. Scand J Gastroenterol. 2017 Jun - Jul;52(6-7):617-623 [PMID: 28276834]
  135. JAMA Intern Med. 2017 Sep 1;177(9):1308-1315 [PMID: 28604925]
  136. J Infect Chemother. 2019 Jul;25(7):509-513 [PMID: 30879978]
  137. Hematology. 2004 Aug;9(4):291-6 [PMID: 15621737]
  138. J Med Case Rep. 2014 Oct 08;8:332 [PMID: 25297051]
  139. Int J Mol Sci. 2017 Jun 23;18(7): [PMID: 28644389]
  140. Chest. 2018 Nov;154(5):1202-1212 [PMID: 29959904]
  141. J Biol Chem. 2001 Apr 20;276(16):13289-94 [PMID: 11278768]
  142. Int J Antimicrob Agents. 2018 Dec;52(6):762-770 [PMID: 30176355]
  143. Semin Respir Crit Care Med. 2016 Dec;37(6):829-838 [PMID: 27960207]
  144. Cochrane Database Syst Rev. 2014 Oct 09;(10):CD002109 [PMID: 25300166]
  145. Clin Gastroenterol Hepatol. 2015 Feb;13(2):369-376.e3 [PMID: 25111234]
  146. Clin Ther. 2008 Oct;30(10):1870-9 [PMID: 19014842]
  147. N Engl J Med. 2019 Jul 11;381(2):111-120 [PMID: 31291514]
  148. Antimicrob Agents Chemother. 2014 Aug;58(8):4392-8 [PMID: 24841264]
  149. Am J Med. 2017 Dec;130(12):1449-1457.e9 [PMID: 28739200]
  150. Cochrane Database Syst Rev. 2018 Oct 29;10:CD010257 [PMID: 30371937]
  151. J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):72-81.e1 [PMID: 29017833]
  152. J Allergy Clin Immunol. 2012 Dec;130(6):1442-2.e5 [PMID: 23195529]
  153. J Antimicrob Chemother. 2014 Jan;69(1):111-6 [PMID: 23943391]
  154. J Infect. 2013 Dec;67(6):516-23 [PMID: 24055804]
  155. Drug Saf. 2017 Dec;40(12):1171-1198 [PMID: 28755095]
  156. J Emerg Med. 2012 May;42(5):612-20 [PMID: 21742459]
  157. Microb Genom. 2018 Sep;4(9): [PMID: 30207515]

MeSH Term

Administration, Oral
Anti-Bacterial Agents
Drug Prescriptions
Drug Resistance, Bacterial
Humans
Respiratory Tract Infections

Chemicals

Anti-Bacterial Agents

Word Cloud

Created with Highcharts 10.0.0treatmentoralrespiratorytractrecommendationskeysappropriatechoiceantibioticExacerbationchronicobstructivepulmonarydiseasecommunity-acquiredpneumoniafrequentinfectionslowerdailyclinicalpracticeAntibioticselectioncrucialcomponentcasesperformedempiricallyScientificsocietiesmaketherapeuticbasedscientificevidence/expertgreathelpcliniciansBeta-lactamsfluoroquinolonesmacrolidescommonlyuseddrugsadministrationpracticalpointviewthreeeffectivenesssafetyecologicalimpactpatient'smicrobiotaincludingdevelopmentresistancewillassesseddepthreview[Threeinfections]

Similar Articles

Cited By